NR3C1 and prostate carcinoma: Several of these genes either directly or their transcriptional activity falls in two predominant pathways: glucocorticoid receptor signalling and tumour microenvironment pathways indicating that these two pathways could be important players in prostate cancer progression in our HUBCM AA cohort.